Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 620.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 630.00 |
Description | Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management. |
Source |
Synonyms | 5,7-Dihydroxy-6,8-diprenylchromone |
Molecular Weight | 314.38 |
Formula | C19H22O4 |
CAS No. | 162616-72-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lupichromone 162616-72-0 5,7-Dihydroxy-6,8-diprenylchromone inhibitor inhibit